NORM-HF - Clinical Trial
¿Cuál es el Propósito de este estudio?
24-month enrollment period and up to 5 years of follow-up.
This study is testing a system called the NORM System for people who have heart failure. The system helps measure and watch a large vein in the body called the inferior vena cava, which can show how much fluid is in the body. This information can help doctors and patients better manage heart failure.
The goal of the study is to see if using this system is safe and helps doctors make better decisions about treatment so patients can feel better and avoid problems from fluid buildup.
¿Quién puede participar en el Estudio?
People can join this study if they have a type of heart failure called Class II or Class III, which means they have some symptoms but can still do many daily activities. They must be taking stable heart failure medicines that follow standard medical guidelines. This means their treatment plan has not changed recently and is based on common care used by doctors.
¿Qué Implica?
This study is testing a system called the NORM System to help care for people with heart failure. People in the study will be placed into one of two groups by chance. One group will use the NORM System, which measures fluid in the body to help guide treatment decisions. The other group will receive usual care without this system.
The goal of the study is to see if using the NORM System helps reduce worsening heart problems and lowers the risk of death related to heart disease compared to standard care.